1. |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108.
|
2. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
3. |
Piperis M, Tsoukalas N. Stereotactic body radiation therapy and surgery for early stage non-small cell lung cancer. J Invest Surg, 2017: 1-3.
|
4. |
Berkovic P, Paelinck L, Gulyban A, et al. Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome prediction. Acta Oncol, 2017, 56(11): 1656-1659.
|
5. |
Pless M, Stupp R, Ris HB, et al. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet, 2015, 386(9998): 1049-1056.
|
6. |
Zhao X, Wen X, Wei W, et al. Predictors for the efficacy of Endostar combined with neoadjuvant chemotherapy for stage IIIA (N2) NSCLC. Cancer Biomark, 2017, 21(1): 169-177.
|
7. |
Savic M, Kontic M, Ercegovac M, et al. Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience. Thorac Cancer, 2017, 8(5): 393-401.
|
8. |
Wang HH, Deng L, Wen QL, et al. Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer. Oncotarget, 2017, 8(38): 62998-63013.
|
9. |
Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0). Available at:http://handbook.cochrane.org.
|
10. |
唐翠萍, 秦思, 伍万春, 等. Ⅲa 期非小细胞肺癌新辅助化疗的疗效分析及应用价值.中国肺癌杂志, 2017, 20(2): 100-106.
|
11. |
陈树兴, 陈新富, 郭立人, 等.ⅢA 期非小细胞肺癌患者术前新辅助化疗的临床分析.福建医药杂志, 2013, 35(6): 118-120.
|
12. |
温永富, 宋旭东. Ⅲa 期非小细胞肺癌新辅助化疗的临床评价.中国综合临床, 2005, 21(7): 624-625.
|
13. |
石鹏飞, 张晓明. MVP 方案新辅助化疗治疗ⅢA 期非小细胞肺癌的疗效观察.实用癌症杂志, 2016, 31(5): 769-771.
|
14. |
张国庆, 韩峰, 高胜利, 等.新辅助化疗对 165 例 Ⅲa 期非小细胞肺癌患者术后生存的影响分析. 肿瘤研究与临床, 2007, 19(7): 470-473.
|
15. |
周明, 王远东, 邵中夫, 等. 新辅助化疗对 Ⅲa 期非小细胞肺癌手术及围术期并发症的影响.广东医学, 2004, 25(9): 1053-1054.
|
16. |
李勇生, 杨文东, 黄宇康, 等.新辅助化疗对ⅢA 期非小细胞肺癌手术疗效的影响. 中国基层医药, 2006, 13(2): 201-202.
|
17. |
李坚, 俞力超, 张德厚, 等.新辅助化疗对提高ⅢA 期非小细胞肺癌手术切除率的作用.中国肿瘤临床与康复, 2002, 9(6): 67-69.
|
18. |
游庆军, 王嘉玮, 蒋锡初, 等.新辅助化疗在 Ⅲa 期非小细胞肺癌治疗中的应用.现代肿瘤医学, 2006, 14(7): 827-828.
|
19. |
王嘉玮, 游庆军, 蒋锡初, 等.新辅助化疗在 Ⅲa 期肺癌治疗中的应用. 实用全科医学, 2006, 4(1): 15-16.
|
20. |
张艳峰, 苏文中.新辅助化疗治疗 Ⅲa 期非小细胞肺癌的临床观察. 中国继续医学教育, 2015, (3): 66-67.
|
21. |
李宇晖, 高爽, 庄思敏, 等.紫杉醇加顺铂的新辅助化疗对提高ⅢA 期非小细胞肺癌手术切除率的临床作用. 岭南现代临床外科, 2004, 4(3): 231-232.
|
22. |
张立新, 王启文, 曲明江, 等.新辅助化疗对 IIIA 期非小细胞肺癌外科治疗的影响. 中国误诊学杂志, 2011, 11(30): 7401-7402.
|
23. |
Milroy R, Macbeth F. Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer. Thorax, 1995, 50 Suppl 1: S25-S30.
|
24. |
Nagai K, Tsuchiya R, Mori T, et al. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). J Thorac Cardiovasc Surg, 2003, 125(2): 254-260.
|
25. |
Misumi K, Harada H, Tsubokawa N, et al. Clinical benefit of neoadjuvant chemoradiotherapy for the avoidance of pneumonectomy; assessment in 12 consecutive centrally located non-small cell lung cancers. Gen Thorac Cardiovasc Surg, 2017, 65(7): 392-399.
|
26. |
Tang C, Qin S, Wu W, et al. Efficacy and Potential Application of Neoadjuvant Chemotherapy in Patients with IIIa Stage Non-small Cell Lung Cancer. Zhongguo Fei Ai Za Zhi, 2017, 20(2): 100-106.
|
27. |
Wang Y, Wang X, Yan S, et al. Progress of neoadjuvant therapy combined with surgery in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi, 2017, 20(5): 352-360.
|
28. |
Bruzzi JF, Komaki R, Walsh GL, et al. Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management. Radiographics, 2008, 28(2): 551-560.
|
29. |
Duan X, Liu Z, Xu S. Research progresses of circulating tumor cells in diagnosis and treatment of early lung cancer. zhongguo fei ai za zhi, 2017, 20(10): 703-709.
|
30. |
Spaggiari L, Casiraghi M, Guarize J, et al. Outcome of Patients With pN2 " Potentially Resectable” Nonsmall Cell Lung Cancer Who Underwent Surgery After Induction Chemotherapy. Semin Thorac Cardiovasc Surg, 2016, 28(2): 593-602.
|
31. |
Francolini G, Ferrari K, Scotti V. Neoadjuvant approach for nonsmall cell lung cancer: overview of the current issues. Curr Opin Oncol, 2017, 29(2): 123-128.
|
32. |
Zhu J, Zhang HP, Jiang S, et al. Neoadjuvant chemotherapy by bronchial arterial infusion in patients with unresectable stage III squamous cell lung cancer. Ther Adv Respir Dis, 2017, 11(8): 301-309.
|